Intellipharmaceutics International Inc. (IPCI)

[Samsa]

wimike, actually that is our problem. We actually do have a lot going for us! Regabatin is worth a great deal even if it has no upfront payment, I am sure milestone payments would easily be worth 30 to 50 million. Rexista, is worth a bit as well. we are at the end so probably a 10 million upfront with more upon approval. then royalties to boot. Podras if proved could be licensed for tens of millions to multiple companies to be added as a Supplement.

The problem is this all requires Odidi to make a deal. My only thought is Boyd has just invested millions at this point. what is he thinking? he hasn't given up. Odidi just needs to make some deals.